Cargando…
Population Health and Cost-Effectiveness Implications of a “Treat All” Recommendation for HCV: A Review of the Model-Based Evidence
The World Health Organization HCV Guideline Development Group is considering a “treat all” recommendation for persons infected with hepatitis C virus (HCV). We reviewed the model-based evidence of cost-effectiveness and population health impacts comparing expanded treatment policies to more limited...
Autores principales: | Cipriano, Lauren E., Goldhaber-Fiebert, Jeremy D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157435/ https://www.ncbi.nlm.nih.gov/pubmed/30288448 http://dx.doi.org/10.1177/2381468318776634 |
Ejemplares similares
-
Pricing Treatments Cost-Effectively when They Have Multiple Indications: Not Just a Simple Threshold Analysis
por: Goldhaber-Fiebert, Jeremy D., et al.
Publicado: (2023) -
Cost-Effectiveness Analysis of Risk-Factor Guided and Birth-Cohort Screening for Chronic Hepatitis C Infection in the United States
por: Liu, Shan, et al.
Publicado: (2013) -
Estimating the cost of cervical cancer screening in five developing countries
por: Goldhaber-Fiebert, Jeremy D, et al.
Publicado: (2006) -
Prevention and control of dengue and chikungunya in Colombia: A cost-effectiveness analysis
por: Claypool, Anneke L., et al.
Publicado: (2021) -
Modeling the Cost-Effectiveness of Interventions to Prevent Plague in Madagascar
por: Malloy, Giovanni S. P., et al.
Publicado: (2021)